Application of molecular docking and PSO–SVR intelligent approaches in antimalarial activity prediction of enantiomeric cycloguanil analogues

References

• World Health Organization (2018), World Malaria Day, 25 April 2018; Available at http://www.who.int/campaigns/malaria-day/2018/event/en/.
   Google Scholar
• D.A. Warrell, T.M. Cox, and J.D. Firth, The Oxford Textbook of Medicine, 5th ed., Oxford University Press, Oxford, 2010.
   Google Scholar
• A. Nzila, The past, present and future of antifolates in the treatment of Plasmodium falciparum infection, J. Antimicrob. Chemother. 57 (2006), pp. 1043–1054.
   Google Scholar
• A. Gregson and C.V. Plowe, Mechanisms of resistance of malaria parasites to antifolates, Pharmacol. Rev. 57 (2005), pp. 117–145.
   Google Scholar
• S. Kamchonwongpaisan, R. Quarrell, N. Charoensetakul, R. Ponsinet, T. Vilaivan, J. Vanichtanankul, B. Tarnchompoo, W. Sirawaraporn, G. Lowe, and Y. Yuthavong, Inhibitors of multiple mutants of Plasmodium falciparum dihydrofolate reductase and their antimalarial activities, J. Med. Chem. 47 (2004), pp. 673–680.
   Web of Science ®Google Scholar
• Y. Yuthavong, B. Tarnchompoo, T. Vilaivan, P. Chitnumsub, S. Kamchonwongpaisan, S.A. Charman, D.N. McLennan, K.L. White, L. Vivas, E. Bongard, C. Thongphanchang, S. Taweechai, J. Vanichtanankul, R. Rattanajak, U. Arwon, P. Fantauzzi, J. Yuvaniyama, W.N. Charman, and D. Matthews, Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target, Proc. Natl. Acad. Sci. U.S.A. 109 (2012), pp. 16823–16828.
   PubMed Web of Science ®Google Scholar
• Y. Yuthavong, T. Vilaivan, N. Chareonsethakul, S. Kamchonwongpaisan, W. Sirawaraporn, R. Quarrell, and G. Lowe, Development of a lead inhibitor for the A16V+S108T mutant of dihydrofolate reductase from the cycloguanil-resistant strain (T9/94) of Plasmodium falciparum, J. Med. Chem. 43 (2000), pp. 2738–2744.
   Web of Science ®Google Scholar
• D.R. Brocks and R. Mehvar, Stereoselectivity in the pharmacodynamics and pharmacokinetics of the chiral antimalarial drugs, Clin. Pharmacokinet. 42 (2003), pp. 1359–1382.
   PubMed Web of Science ®Google Scholar
• M.A. Biamonte, J. Wanner, and K.G. Le Roch, Recent advances in malaria drug discovery, Bioorg. Med. Chem. Lett. 23 (2013), pp. 2829–2843.
   PubMed Web of Science ®Google Scholar
• M. Schmidt, H. Sun, P. Rogne, G.K.E. Scriba, C. Griesinger, L.T. Kuhn, and U.M. Reinscheid, Determining the absolute configuration of (+)-Mefloquine HCl, the side-effect-reducing enantiomer of the antimalaria drug Lariam, J. Am. Chem. Soc. 134 (2012), pp. 3080–3083.
   PubMed Web of Science ®Google Scholar
• F. Felluga, M. Fermeglia, M. Ferrone, G. Pitacco, S. Pricl, and E. Valentin, Computational studies on the enantioselectivity of α-chymotrypsin towards β-carbomethoxy-γ-lactams, Tetrahedral: Asymmetry 13 (2002), pp. 475–489.
   Google Scholar
• C. Fernanses, M.E. Tiritan, Q. Cass, V. Kairys, M.X. Fernandes, and M. Pinto, Enantioseparation and chiral recognition mechanism of new chiral derivatives of xanthones on macrocyclic antibiotic stationary phases, J. Chromatogr. A 1241 (2012), pp. 60–68.
   PubMed Web of Science ®Google Scholar
• A.M. Sørensen, C.H. Hansen, S. Bonomo, L. Olsen, F.S. Jørgensen, J.J. Weisser, A.C. Kretschmann, and B. Styrishave, Enantioselective endocrine disrupting effects of omeprazole studied in the H295R cell assay and by molecular modeling, Toxicol. In Vitro. 34 (2016), pp. 71–80.
   Google Scholar
• W. Xu, J. Huang, R. Jiang, and M. Yuan, Crystal structures, absolute configurations and molecular docking studies of naftopidil enantiomers as α1D-adrenoceptor antagonists, Acta Pharm. Sin. B. 7 (2017), pp. 496–501.
   PubMed Web of Science ®Google Scholar
• A. Lavecchia, S. Cosconati, E. Novellino, E. Calleri, C. Temporini, G. Massolini, G. Carbonara, G. Fracchiolla, and F. Loiodice, Exploring the molecular basis of the enantioselective binding of penicillin G acylase towards a series of 2-aryloxyalkanoic acids: A docking and molecular dynamics study, J. Mol. Graph. Model. 25 (2007), pp. 773–783.
   PubMed Web of Science ®Google Scholar
• S. Kulatee, P. Toochinda, A. Suksangpanomrung, and L. Lawtrakul, Theoretical investigation of the enantioselective complexations between PfDHFR and cycloguanilloguanil derivatives, Sci. Pharm. 85 (2017). Available at http://www.mdpi.com/2218-0532/85/4/37.
   Google Scholar
• M.J. Frisch, G.W. Trucks, H.B. Schlegel, G.E. Scuseria, M.A. Robb, J.R. Cheeseman, G. Scalmani, V. Barone, G.A. Petersson, H. Nakatsuji, X. Li, M. Caricato, A. Marenich, J. Bloino, B.G. Janesko, R. Gomperts, B. Mennucci, H.P. Hratchian, J.V. Ortiz, A.F. Izmaylov, J.L. Sonnenberg, D. Williams-Young, F. Ding, F. Lipparini, F. Egidi, J. Goings, B. Peng, A. Petrone, T. Henderson, D. Ranasinghe, V.G. Zakrzewski, J. Gao, N. Rega, G. Zheng, W. Liang, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, T. Vreven, K. Throssell, J.A. Montgomery, Jr., J.E. Peralta, F. Ogliaro, M. Bearpark, J.J. Heyd, E. Brothers, K.N. Kudin, V.N. Staroverov, T. Keith, R. Kobayashi, J. Normand, K. Raghavachari, A. Rendell, J.C. Burant, S.S. Iyengar, J. Tomasi, M. Cossi, J.M. Millam, M. Klene, C. Adamo, R. Cammi, J.W. Ochterski, R.L. Martin, K. Morokuma, O. Farkas, J.B. Foresman, and D. Fox, Gaussian 09, Revision A.02, Gaussian, Inc., Wallingford CT, 2016.
   Google Scholar
• Y. Zhao and D.G. Truhlar, The M06 suite of density functionals for main group thermochemistry, thermochemical kinetics, noncovalent interactions, excited states, and transition elements: Two new functionals and systematic testing of four M06-class functionals and 12 other functionals, Theor. Chem. Account. 120 (2008), pp. 215–241.
   Web of Science ®Google Scholar
• Molecular Operating Environment (MOE), 2013.08; Chemical Computing Group ULC, 1010 Sherbooke St. West, Suite #910, Montreal, QC, Canada, H3A 2R7, 2018.
   Google Scholar
• D.E. Hinkle, W. Wiersma, and S.G. Jurs, Applied Statistics for Behavioral Sciences, 5th ed., Cengage Learning US, 2003.
   Google Scholar
• J. Vanichtanankul, S. Taweechai, C. Uttamapinant, P. Chitnumsub, T. Vilaivan, Y. Yuthavong, and S. Kamchonwongpaisan, Combined spatial limitation around residues 16 and 108 of Plasmodium falciparum dihydrofolate reductase explains resistance to cycloguanil, Antimicrob. Agents Chemother. 56 (2012), pp. 3928–3935.
   PubMed Web of Science ®Google Scholar
• H.M. Berman, K. Henrick, and H. Nakamura, Announcing the worldwide Protein Data Bank, Nat. Struct. Biol. 10 (2003), p. 980.
   Google Scholar
• Accelrys. Discovery Studio Modeling Environment Release 4.0; Accelrys Inc.: San Diego, CA, USA, 2016.
   Google Scholar
• G.M. Morris, R. Huey, W. Lindstrom, M.F. Sanner, R.K. Belew, D.S. Goodsell, and A.J. Olson, AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility, J. Comput. Chem. 85 (2017), pp. 2785–2791.
   Google Scholar
• G.M. Morris, D.S. Goodsell, R.S. Halliday, R. Huey, W.E. Hart, R.K. Belew, and A.J. Olson, Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function, J. Comp. Chem. 19 (1998), pp. 1639–1662.
   Google Scholar
• C.E. Russell and S. Yuhui, Particle swarm optimization: Developments, applications and resources, Proceedings of the 2001 Congress on Evolutionary Computation, Seoul, South Korea, (2001), pp. 81–86. Available at https://ieeexplore.ieee.org/document/934374.
   Google Scholar
• S.K. Tchomte and M. Gourgand, Particle swarm optimization: A study of particle displacement for solving continuous and combinatorial optimization problems, Int. J. Prod. Econ. 121 (2009), pp. 57–67.
   Web of Science ®Google Scholar
• D.K. Agrafiotis and W. Cedeño, Feature selection for structure–activity correlation using binary particle swarms, J. Med. Chem. 45 (2002), pp. 1098–1107.
   Google Scholar
• L. Lawtrakul and C. Prakasvudhisarn, Correlation studies of HEPT derivatives using swarm intelligence and support vector machines, Monatsh. Chem. 136 (2005), pp. 1681–1691.
   Web of Science ®Google Scholar
• M. Goodarzi, W. Saeys, O. Deeb, S. Pieters, and H.Y. Vander, Particle swarm optimization and genetic algorithm as feature selection techniques for the QSAR modeling of imidazo[1,5-a]pyrido[3,2-e]pyrazines, inhibitors of phosphodiesterase 10A, Chem. Biol. Drug. Des. 82 (2013), pp. 685–696.
   PubMed Web of Science ®Google Scholar
• Y. Wang, J.J. Huang, N. Zhou, D.S. Cao, J. Dong, and H.X. Li, Incorporating PLS model information into particle swarm optimization for descriptor selection in QSAR/QSPR, J. Chemom. 29 (2015), pp. 627–636.
   Web of Science ®Google Scholar
• C. Cortes and V. Vapnik, Support-vector networks, Mach. Learn. 20 (1995), pp. 273–297.
   Google Scholar
• A.J. Smola and B. Schölkopf, A tutorial on support vector regression, Stat. Comput. 14 (2004), pp. 199–222.
   Google Scholar
• B. Stephen and V. Lieven, Convex Optimization. Cambridge University Press, Cambridge, 2004.
   Google Scholar
• R. Darnag, B. Minaoui, and M. Fakir, QSAR models for prediction study of HIV protease inhibitors using support vector machines, neural networks and multiple linear regression. Arabian J. Chem. 10 (2017), pp. S600–S608.
   Google Scholar
• R. Leach and V.J. Gillet, An introduction to chemoinformatics, J. Am. Chem. Soc. 126 (2004), pp. 7729–7730.
   Google Scholar
• G. Schneider and P. Wrede, Artificial neural networks for computer-based molecular design, Prog. Biophys. Mol. Bio. 70 (1998), pp. 175–222.
   PubMed Web of Science ®Google Scholar
• R. Veerasamy, H. Rajak, A. Jain, S. Sivadasan, C.P. Varghese, and R.K. Agrawal, Validation of QSAR models – strategies and importance, Int. J. Drug Des. Discov. 2 (2011), pp. 511–519.
   Google Scholar
• Y. Yuthavong. Basis for antifolate action and resistance in malaria, Microbes. Infect. 4 (2002), pp. 175–182.
   Web of Science ®Google Scholar
• L. Adane and P.V. Bharatam, 3D-QSAR analysis of cycloguanil derivatives as inhibitors of A16V + S108T mutant Plasmodium falciparum dihydrofolate reductase enzyme, J. Mol. Graph. Model. 28 (2009), pp. 357–367.
   PubMed Web of Science ®Google Scholar
• J. Gasteiger and M. Marsili, Iterative partial equalization of orbital electronegativity—a rapid access to atomic charges, Tetrahedron 36 (1980), pp. 3219–3228.
   Google Scholar
• P. Labute, A widely applicable set of descriptors. J. Mol. Graph. Model. 18 (2000), pp. 464–477.
   PubMed Web of Science ®Google Scholar
• R.S. Pearlman and K.M. Smith, Novel software tools for chemical diversity, Perspect. Drug Discov. Des. 9 (1998), pp. 339–353.
   Google Scholar
• S. Basak and D. Mills, Quantitative structure-activity relationships for cycloguanil analogs as PfDHFR inhibitors using mathematical molecular descriptors. SAR QSAR Environ. Res. 21 (2010), pp. 215–229.
   PubMed Web of Science ®Google Scholar
• D. Hecht, M. Cheung, and G.B. Fogel, Docking scores and QSAR using evolved neural networks for the Pan-inhibition of wild-type and mutant PfDHFR by cycloguanil derivatives, IEEE Congress on Evolutionary Computation, (2009), pp. 262–269. Available at https://ieeexplore.ieee.org/document/4982957.
   Google Scholar
• P. Maitarad, S. Kamchonwongpaisan, J. Vanichtanankul, T. Vilaivan, Y. Yuthavong, and S. Hannongbua, Interactions between cycloguanil derivatives and wild type and resistance-associated mutant Plasmodium falciparum dihydrofolate reductases, J. Comput. Aided Mol. Des. 23 (2009), pp. 241–252.
   PubMed Web of Science ®Google Scholar